Company news
Foresee Pharmaceuticals Co., Ltd. news in 2023
Foresee Pharmaceuticals Co., Ltd.'s news releases, calls and decks from 2023, newest first.
Foresee Pharmaceuticals to Present at the American Heart Association Annual Meeting Focusing on its ALDH2 activator FP-045 in Pulmonary Hypertension Associated with Interstitial Lung Disease
October 31, 2023
Foresee Pharmaceuticals to Present Phase 1/2 Fanconi Anemia Clinical Study Design for its ALDH2 activator FP-045 at the Fanconi Anemia Research Fund 2023 Scientific Symposium
October 2, 2023
Foresee Pharmaceuticals Announces Publication of Preclinical Data in Nature Communications
October 2, 2023
Foresee Pharmaceuticals Announces Completion of US$42.3 Million Financing
June 28, 2023
Foresee Pharmaceuticals Presented Poster on MMP-12 inhibitor, FP-020, in Genetic Model of Sarcoidosis at the WASOG 2023 International Conference on Sarcoidosis and Interstitial Lung Diseases
June 22, 2023
Decks in 2023
- Investor Presentation (February 2023)
Investor deck · 37 slides · Feb 23, 2023